WWOX and ovarian carcinoma: In parallel, WWOX status has no impact on cisplatin response (Figure 2c) to complement the previous data generated with stable transfectants.21 To mimic the loss/reduction of WWOX as it happens in the course of cancer, we knocked down endogenous WWOX in ovarian cancer cells to monitor the impact on cell survival.